Abstract
Background. Point-of-care thromboelastometry (ROTEM®) can be used to assess coagulation in whole blood. In the ROTEM® FIBTEM test, cytochalasin D eliminates the contribution of platelets to the whole blood clot; hence, only the remaining elements, including fibrinogen/fibrin, red blood cells and factor XIII, contribute to clot strength. We investigated the relationships between FIBTEM maximum clot firmness (MCF), whole blood fibrinogen concentration and plasma fibrinogen concentration to determine the impact of haematocrit on these parameters during cardiac surgery. Materials and methods. The relationships between FIBTEM MCF and both whole blood fibrinogen concentration and plasma fibrinogen concentration (Clauss assay) were evaluated pre-operatively and after cardiopulmonary bypass/protamine administration in haematocrit-based subgroups. Results. The study included 157 patients. The correlation coefficient rho between FIBTEM MCF and plasma fibrinogen concentration was 0.68 at baseline and 0.70 after protamine, while that between FIBTEM MCF and whole blood fibrinogen concentration was 0.74 at baseline and 0.72 after protamine (all P
Original language | English |
---|---|
Pages (from-to) | 412-418 |
Number of pages | 7 |
Journal | Blood Transfusion |
Volume | 11 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2013 |
Keywords
- Cardiac surgery
- Fibrinogen
- FIBTEM
- Haematocrit
- Thromboelastometry
ASJC Scopus subject areas
- Hematology
- Immunology and Allergy